Director, New Approach Methodologies (NAMs), Translational Science

The Director, New Approach Methodologies (NAMs) for toxicology and drug development, will lead the strategy, development, and execution of multi-sector scientific partnerships to advance, validate, and qualify innovative alternative models for drug development and human safety toxicity testing. These efforts will be under the banner of the NAMs Validation and Qualification Network (VQN) that is currently being stood up as a pillar to the Complement Animal Research in Experimentation (Complement-ARIE) Consortium facilitated by the National Institutes of Health (NIH). The projects within the VQN will include all types of NAMs, including in silico approaches, in vitro (e.g. microphysiological systems (MPS), organoids, and advanced cell/tissue systems), in chemico, and ex vivo, and the goal will be to drive these NAMs to a state of readiness for acceptance by the appropriate regulatory body. This role sits at the intersection of translational science, regulatory science, and collaborative innovation. The Director will work closely with biopharmaceutical, chemical, agrichemical, and comestics companies, regulatory agencies, academic investigators, and patient-focused organizations to accelerate the adoption of scientifically robust, fit-for-purpose models that improve predictive safety assessment and drug development and reduce reliance on traditional animal testing. This position will report to the Senior Vice President of Translational Science within the Science Partnerships department and is based at the FNIH offices located in North Bethesda, MD. The ideal candidate brings deep expertise in preclinical drug development and toxicology, paired with the ability to lead complex, precompetitive collaborations, and design projects that will move toward regulatory acceptance. Key Responsibilities Scientific & Program Leadership & Portfolio Management Develop and lead a strategic portfolio of programs focused on NAMs for drug development and human safety/toxicity assessment Identify high-impact use cases where NAMs can be developed precompetitively for validation and qualification for regulatory agencies, including FDA, EMA, EPA, and others in the US and globally Facilitate group creation of scientific frameworks for model validation, context of use (COU) definition, and evidentiary standards Design, launch, and manage multi-partner collaborations across industry, academia, government, and nonprofits Build trusted relationships with biopharma, chemical, agrichemical, and cosmetics R&D leaders, regulatory scientists, and academic innovators Regulatory Science & Qualification Pathways Lead efforts to align validation strategies with regulatory expectations (e.g., FDA, EMA, PMDA, EPS, OECD, etc.) Translate emerging science into regulatory-ready, validated models for submission to the relevant qualification programs (e.g., iSTAND, ENTRÉE, OECD, etc.) Program Oversight & Delivery Ensure rigorous governance of all of the VQN and each precompetitive project developed Aid the VQN project leads on milestone tracking and financial stewardship Lead cross-functional workstreams including internal staff and external partners to address key needs in the NAMs validation and qualification space Field Building & Thought Leadership Represent the organization in scientific and policy forums and partner interactions Contribute to publications and consensus frameworks that advance the field Compensation details: 185000-225000 Yearly Salary PI2117c39d0722-25448-40185326